Compositions and methods for treating hypertension
Abstract:
The technology described herein is directed to agents that reduce the level of oxidant-modified ET-B Cys405, Cys403, or Cys402 and the identification and use of such agents for, e.g. to treat hypertension.
Public/Granted literature
Information query
Patent Agency Ranking
0/0